This company is in an early growth phase with technology that has global implications along with an FDA approval ready in the pipeline.
All companies will suffer during this period, one would be foolish to expect otherwise.
I expect this company to make its mark in the medical industry when the world rebalances.
- Forums
- ASX - By Stock
- IME
- Ann: Quarterly Cash Flow and Summary of Activities
Ann: Quarterly Cash Flow and Summary of Activities, page-130
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IME (ASX) to my watchlist
|
|||||
Last
42.0¢ |
Change
0.015(3.70%) |
Mkt cap ! $19.12M |
Open | High | Low | Value | Volume |
41.5¢ | 42.0¢ | 39.0¢ | $15.94K | 39.45K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 16200 | 40.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
44.0¢ | 20000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 16200 | 0.400 |
1 | 80 | 0.395 |
1 | 13888 | 0.360 |
1 | 40000 | 0.350 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.440 | 20000 | 1 |
0.455 | 38377 | 1 |
0.470 | 10 | 1 |
0.500 | 20000 | 1 |
0.550 | 18000 | 1 |
Last trade - 14.59pm 19/06/2024 (20 minute delay) ? |
Featured News
IME (ASX) Chart |
The Watchlist
CC9
CHARIOT CORPORATION LTD
Shanthar Pathmanathan, MD
Shanthar Pathmanathan
MD
Previous Video
Next Video
SPONSORED BY The Market Online